NANTKWEST
NantKwest is a clinical-stage immunotherapy company focused on harnessing the immune system to treat disease. It is a biotechnology company, engages in developing immunotherapeutic agents for various clinical conditions in the United States. The company’s product candidates include activated natural killer candidates for the treatment of virally-induced cancers, such as human papilloma virus-induced cervical, and head and neck cancers; ebola; and serious viral, fungal, and bacterial infections, as well as that is in Phase II clinical trials for the treatment of polyoma virus-induced merkel cell carcinoma.
NANTKWEST
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2002-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.nantkwest.com
Total Employee:
51+
Status:
Active
Contact:
(858)633-0300
Email Addresses:
[email protected]
Total Funding:
103.5 M USD
Technology used in webpage:
SPF Domain Not Resolving IPv6 Microsoft Azure DNS GoDaddy DNS Person Schema Gravatar Profiles MailChimp SPF Akamai Hosted Zoom Video Conferencing
Similar Organizations
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Atlas Venture
Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Brenus Pharma
Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Stock Details
Investors List
Patrick Soon-Shiong
Patrick Soon-Shiong investment in Post-IPO Equity - NantKwest
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-04-04 | Viracta Therapeutics | NantKwest investment in Series B - Viracta Therapeutics | 18.4 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-10-26 | NantKwest Names Richard Adcock Chief Executive Officer |
Official Site Inspections
http://www.nantkwest.com Semrush global rank: 701.63 K Semrush visits lastest month: 26.19 K
- Host name: 74.206.101.41
- IP address: 74.206.101.41
- Location: Phoenix United States
- Latitude: 33.3322
- Longitude: -111.9942
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85044
More informations about "NantKwest"
ImmunityBio and NantKwest Complete Merger
Mar 9, 2021 · ImmunityBio, Inc. and NantKwest, Inc. (NASDAQ: NK), today announced the completion of their previously announced 100% stock-for-stock merger.See details»
ImmunityBio and NantKwest to Merge, Creating a Leading …
Dec 21, 2020 · Together, ImmunityBio and NantKwest will have a broad, clinical-stage pipeline – including 13 assets in clinical trials and 11 in Phase II to III – as well as a robust early stage …See details»
NantKwest - LinkedIn
NantKwest (NASDAQ: NK) is a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer (NK) cells to treat...See details»
ImmunityBio Company Profile - Office Locations, Competitors
Oct 29, 2024 · ImmunityBio (formerly known as NantKwest) is a clinical-stage immunotherapy company focused on harnessing the power of the immune system using natural killer (NK) …See details»
NantKwest and ImmunityBio Announce Complete Response in …
Jan 14, 2020 · NantKwest is the leading producer of clinical dose forms of off-the-shelf Natural Killer (NK) cell therapies. The activated NK cell platform is designed to destroy cancer and …See details»
NantKwest - Crunchbase Company Profile & Funding
NantKwest is a clinical-stage immunotherapy company focused on harnessing the immune system to treat disease. It is a biotechnology company, engages in developing …See details»
Stockholders of NantKwest Approve Merger With ImmunityBio
Mar 8, 2021 · Final voting results for NantKwest’s special meeting of stockholders will be disclosed in a Form 8-K to be filed by NantKwest with the Securities and Exchange …See details»
NantKwest Launches First-in-class, First-in-human Phase I Clinical ...
Jun 24, 2019 · First engineered, GMP-grade, cryopreserved, off-the-shelf, bi-specific NK cell therapy to enter human clinical trials targeting PD-L1 and CD16 in patients with solid tumors.See details»
ImmunityBio and NantKwest Complete Merger - Business Wire
Mar 9, 2021 · ImmunityBio, Inc. and NantKwest, Inc. (NASDAQ: NK), today announced the completion of their previously announced 100% stock-for-stock merger. This fol.See details»
NantKwest Company Profile 2024: Valuation, Investors ... - PitchBook
NantKwest Inc is a United States-based firm functioning in the healthcare sector. It is focused on providing immunotherapeutic agents, especially natural killer cells to treat cancer, infectious …See details»
FDA Authorization for NANT Cancer Vaccine Trials | NantHealth
May 9, 2017 · NantKwest and NantCell announce FDA authorization for the NANT Cancer Vaccine trials - the first combo of innate and adaptive immunotherapy.See details»
ImmunityBio and NantKwest Announce FDA Authorization to …
Feb 11, 2021 · ImmunityBio, Inc. is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious …See details»
NantWorks Company Profile - Office Locations, Competitors
NantWorks is the umbrella organization for an ecosystem of companies: NantHealth, NantOmics, NantBioScience, NantCell, NantKwest, NantPharma, NantMobile, NantStudio, NantCapital …See details»
Altor Bioscience Corporation and NantKwest Inc. Announce
Oct 4, 2016 · NantKwest (Nasdaq:NK) is a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system …See details»
ImmunityBio and NantKwest to Merge, Creating a Leading …
Dec 21, 2020 · Together, ImmunityBio and NantKwest will have a broad, clinical-stage pipeline – including 13 assets in clinical trials and 11 in Phase II to III – as well as a robust early stage …See details»
NantKwest — Harnessing Natural Killer Cells to Treat Cancer
NantKwest's approach combines cell therapy using engineered, off-the-shelf (allogeneic) NK cells with an IL-based fusion protein to activate the T cells — and a cancer vaccine based on an …See details»
NantKwest, ImmunityBio Announce Positive Interim Data on …
Jan 13, 2021 · ImmunityBio, Inc. is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious …See details»
NantKwest $207M IPO Sets Biotech Record for Market Cap
Jul 29, 2015 · NantKwest, Inc. (formerly Conkwest, Inc.), a clinical-stage immunotherapy company focused on harnessing the power of the innate immune system by using the natural …See details»
NantKwest: Taking A Deeper Dive Into Their COVID-19 ... - Seeking …
Jan 15, 2021 · NantKwest and ImmunityBio announced they are preparing to merge to create a juggernaut immunotherapy and cell therapy company. Now, NantKwest investors will have …See details»
NantKwest Launches First-in-Human Targeted NK Phase I Clinical …
Jun 3, 2019 · NantKwest, a member of the NantWorks ecosystem of companies, is an innovative clinical-stage immunotherapy company focused on harnessing the power of the innate …See details»